Lumedx Corp. will present the latest in cardiovascular (CV) imaging, data management and next-generation analytics solutions at the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago. The company said that they will showcase software developed to help heart and vascular hospitals improve outcomes, streamline the delivery of patient care and reduce costs.

Bristol-Myers Squibb Company and Pfizer Inc. released real-world data (RWD) of outcomes associated with direct oral anticoagulants (DOAC) among non-valvular atrial fibrillation (NVAF) patients during the 2017 American Heart Association (AHA) Scientific Sessions, Nov. 11-15 in Anaheim, Calif. The data was compiled using the U.S. Medicare database – the nation’s largest insurer handling more than 1 billion total claims per year – as well as the Department of Defense (DoD) Military Health System (MHS).

Stratasys Ltd. announced that surgeons at the University of Mainz Cardiothoracic and Vascular Surgery Department in Germany are using Stratasys PolyJet 3-D printing to transform the hospital’s surgical planning process for complex, life-critical vascular cases. According to the University hospital, the use of 3-D printed models for surgical planning has seen a significant reduction in costs at the institution when designing and fitting implants — while the hospital reports relevant time-savings during surgery, leading to an improvement in patient outcomes.